StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Before taking the bashing seriuosly

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Apr 11, 2021 11:57am

131 Views

Post# 32974276

RE:RE:Before taking the bashing seriuosly

frewil11 wrote: I saw that Stage Zero nearly brought in 500k on cancer testing, did Tripp touch on this at all and where it came from , and if he didn't why not , that is a very significant jump from last financials .

I think in the effort to gain more transparency we need to present these questions to Rebecca for clarity. Its clear that we on SH can't figure everything out through google research - going forward we need answers from source.

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute